Some Things that You Should Know Regarding Bipolar Depression
Know that bipolar disorder is one type of condition that would affect all kinds of people. The children and adults are being affected by such condition. This is one fact that you must understand. Those women would suffer the most from such type of depression which is known as bipolar depression disorder.
This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.
The bipolar type of disorder is known as manic depression because this is a mental condition wherein you would interchange often between the phases of mania and depression. When you suffer from bipolar depression, you will not have to spend as much time being manic as you spend being depressed.
Such kind of depression is a form of disorder and you must understand that it is easy to mistakenly diagnose as bipolar disorder because of the sameness of these symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is simply another name for such bipolar disorder or the manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. Such is closely related with all of the symptoms of such depressive phase of the bipolar disorder, but very few of the mania.
Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. When the efficacy would be proven as a monotherapy, the new compounds can be tested in such adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. Such switch to mania or the hypomania can perhaps be the result of the active treatment for such bipolar depression.
Some medications like the tricyclic antidepressants and the venlafaxine can be more likely to prove switch as compared to the others but the increased rate of the switch can’t be seen until about 10 weeks of treatment. Thus, the 12-week trials against placebo are needed to determine the risk of switch and establish the continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.